Status:

RECRUITING

Oncologic Outcomes of Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Lead Sponsor:

Ruijin Hospital

Collaborating Sponsors:

Dongfang Hospital Affiliated to Tongji University

Fudan University

Conditions:

Colorectal Cancer

Colon Cancer

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This study is designed to investigate long-term oncologic outcomes of single-incision laparoscopic surgery (SILS) compared to conventional laparoscopic surgery (CLS) for colorectal cancer.

Detailed Description

In order to improve cosmetic effect and reduce postoperative pain, single-incision laparoscopic surgery (SILS) is attracting increasing attention. SILS is considered to be the next major advance in th...

Eligibility Criteria

Inclusion

  • 18 years \< age ≤85 years
  • Tumor located in colon and high rectum ( the lower border of the tumor is above the peritoneal reflection)
  • Pathological or highly suspected colorectal carcinoma
  • Clinically diagnosed cT1-4aN0-2 M0 lesions according to the 8th Edition of AJCC Cancer Staging Manual
  • Tumor size of 5 cm or less
  • ECOG score is 0-1
  • ASA score is Ⅰ-Ⅲ
  • Informed consent

Exclusion

  • Body mass index (BMI) \>35 kg/m2
  • The lower border of the tumor is located distal to the peritoneal reflection
  • Familial adenomatous polyposis (FAP)
  • Inflammatory bowel disease (IBD)
  • Multiple malignant colorectal tumors
  • Pregnant woman or lactating woman
  • Severe mental disease
  • Previous gastrointestinal surgery (except appendectomy )
  • Emergency operation due to complication (bleeding, perforation or obstruction) caused by colorectal cancer
  • Requirement of simultaneous surgery for other disease
  • Simultaneous or metachronous multiple cancers with disease-free survival ≤ 5 years

Key Trial Info

Start Date :

April 8 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2029

Estimated Enrollment :

710 Patients enrolled

Trial Details

Trial ID

NCT04527861

Start Date

April 8 2021

End Date

April 1 2029

Last Update

October 10 2022

Active Locations (11)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (11 locations)

1

The 940th Hospital of Joint Logistic Support Force of Chinese of PLA

Lanzhou, Gansu, China, 730050

2

Shengjing Hospital

Shenyang, Liaoning, China, 110004

3

Liaoning Tumor Hospital & Institute

Shenyang, Liaoning, China, 110801

4

Shandong Provincial Hospital

Jinan, Shandong, China, 250021